We are delighted to announce a new, joint Methods Group between the Cochrane Collaboration, the

We are pleased to announce that earlier this week, Cochrane’s status as a non-State actor (NSA) in official relations with the World Health Organization (WHO) was renewed at the 156th session of the WHO Executive Board meeting in Geneva.

Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024Cochrane proudly celebrates the incredible efforts of our volunteer translators in 2024. Their dedication has been instrumental in breaking language barriers and making high-quality health information accessible to communities worldwide.

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Cochrane peer reviewers can now feature their peer review activity on their Web of Science profiles thanks to a new collaboration between Cochrane and Clarivate. 

A new Cochrane review has found that calor

Cochrane’s Future of Evidence Synthesis Programme has brought about some transformational changesThe arrival of 2025 means that we are now wrapping up our

Cochrane Russia Workshop 28 November 2024: SummaryCochrane workshop « Evidence-Based Approaches to Longevity », organized by Cochrane Russia together with Cochrane China, was held as a part of the International Congress "Quality of Life and Longevity" at the Russian Medical Academy of Continuous Professional Education (RMANPO) on November 28, 2024.Cochrane workshop recording

Cochrane is part of a new global consortium to develop new tools, powered by artificial intelligence (AI), to analyse and synthesise research evidence on the relationships between climate change and human health.

Cochrane has, for over 30 years, built a reputation for producing high-quality evidence syntheses that inform healthcare decisions worldwide.